Financials
- Market Capitalization 44.86 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.05
売上高対価格比率
-280.95
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4294 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.94 USD | -3.09% | +10.59% | +108.89% | -27.69% | 45.68 M USD | ||
| 4300 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.19 USD | -1.65% | -4.80% | -0.83% | -17.36% | 44.95 M USD | ||
| 4303 | VERU Veru Inc. - Common Stock | 2.63 USD | -4.01% | -0.38% | +19.00% | +10.04% | 44.84 M USD | ||
| 4304 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.12 USD | -1.85% | -4.93% | +3.92% | -46.73% | 44.60 M USD |